-
1
-
-
0034675322
-
Scleromyxoedema-like cutaneous diseases in renaldialysis patients
-
Cowper SE, Robin HS, Steinberg SM, Su LD, Gupta S, LeBoit PE. Scleromyxoedema-like cutaneous diseases in renaldialysis patients. Lancet. 2000;356:1000-1001.
-
(2000)
Lancet
, vol.356
, pp. 1000-1001
-
-
Cowper, S.E.1
Robin, H.S.2
Steinberg, S.M.3
Su, L.D.4
Gupta, S.5
LeBoit, P.E.6
-
3
-
-
34548671875
-
Gadolinium-enhanced MR imaging and Nephrogenic Systemic Fibrosis: Retrospective study of a renal replacement therapy cohort
-
Collidge TA, Thomson PC, Mark PB, et al. Gadolinium-enhanced MR imaging and Nephrogenic Systemic Fibrosis: retrospective study of a renal replacement therapy cohort. Radiology. 2007;245:168-175.
-
(2007)
Radiology
, vol.245
, pp. 168-175
-
-
Collidge, T.A.1
Thomson, P.C.2
Mark, P.B.3
-
4
-
-
34347340885
-
Nephrogenic systemic fibrosis: Population study examining the relationship of disease development to gadolinium exposure
-
Deo A, Fogel M, Cowper SE. Nephrogenic systemic fibrosis: population study examining the relationship of disease development to gadolinium exposure. Clin J Am Soc Nephrol. 2007;2:200-202.
-
(2007)
Clin J Am Soc Nephrol
, vol.2
, pp. 200-202
-
-
Deo, A.1
Fogel, M.2
Cowper, S.E.3
-
5
-
-
43049114497
-
Nephrogenic systemic fibrosis associated with gadolinium-based contrast agents: A summary of the medical literature reporting
-
doi:10.1016/ejrad.2008.2.011
-
Broome DR. Nephrogenic systemic fibrosis associated with gadolinium-based contrast agents: a summary of the medical literature reporting. Eur J Radiol. 2008;66:230-234. doi:10.1016/ejrad.2008.2.011.
-
(2008)
Eur J Radiol
, vol.66
, pp. 230-234
-
-
Broome, D.R.1
-
7
-
-
3042703080
-
Presence of CD45RO+ CD34* cells with collagen synthesis activity in nephrogenic fibrosing dermopathy: A new pathogenic hypothesis
-
Ortonne N, Lipsker D, Chantrel F, Bohem N, Grosshans E, Cribier B. Presence of CD45RO+ CD34* cells with collagen synthesis activity in nephrogenic fibrosing dermopathy: a new pathogenic hypothesis. Br J Dermatol. 2004;150:1050-1052.
-
(2004)
Br J Dermatol
, vol.150
, pp. 1050-1052
-
-
Ortonne, N.1
Lipsker, D.2
Chantrel, F.3
Bohem, N.4
Grosshans, E.5
Cribier, B.6
-
8
-
-
33746823044
-
Nephrogenic fibrosing dermopathy and high-dose erythropoietin therapy
-
Swaminathan S, Ahmed I, Mc Carthy JT. Nephrogenic fibrosing dermopathy and high-dose erythropoietin therapy. Ann Intern Med. 2006;145:234-235.
-
(2006)
Ann Intern Med
, vol.145
, pp. 234-235
-
-
Swaminathan, S.1
Ahmed, I.2
Mc Carthy, J.T.3
-
9
-
-
34247889994
-
Safety update on the possible casual relationship between gadolinium-containing-MRI agents and nephrogenic systemic fibrosis
-
Pedersen M. Safety update on the possible casual relationship between gadolinium-containing-MRI agents and nephrogenic systemic fibrosis. J Magn Reson Imaging. 2007;25:881-883.
-
(2007)
J Magn Reson Imaging
, vol.25
, pp. 881-883
-
-
Pedersen, M.1
-
10
-
-
33846223894
-
Nephrogenic systemic fibrosis: A review of 6 cases temporally related to gadodiamide injection (Omniscan)
-
Khurana A, Runge VM, Naranayan M, Greene JF Jr, Nickel AE. Nephrogenic systemic fibrosis: a review of 6 cases temporally related to gadodiamide injection (Omniscan). Radiology. 2007;42:139-145.
-
(2007)
Radiology
, vol.42
, pp. 139-145
-
-
Khurana, A.1
Runge, V.M.2
Naranayan, M.3
Greene Jr, J.F.4
Nickel, A.E.5
-
11
-
-
33847239121
-
Gadolinium-based MR contrast agents and nephrogenic systemic fibrosis
-
Kuo PH, Kanal E, Abu-Alfa AK, Cowper SE. Gadolinium-based MR contrast agents and nephrogenic systemic fibrosis. Radiology. 2007;242:647-649.
-
(2007)
Radiology
, vol.242
, pp. 647-649
-
-
Kuo, P.H.1
Kanal, E.2
Abu-Alfa, A.K.3
Cowper, S.E.4
-
12
-
-
34247230130
-
Gadolinium-based contrast media and the development of nephrogenic systemic fibrosis in patients with renal insufficiency
-
Chewning RH, Murphy KJ. Gadolinium-based contrast media and the development of nephrogenic systemic fibrosis in patients with renal insufficiency. J Vasc Interv Radiol. 2007;18:331-334.
-
(2007)
J Vasc Interv Radiol
, vol.18
, pp. 331-334
-
-
Chewning, R.H.1
Murphy, K.J.2
-
13
-
-
33846541879
-
Gadodiamide-associated nephrogenic systemic fibrosis. why radiologists should be concerned
-
Broome DR, Girguis MS, Baron PW, Cottrell AC, Kjellin I, Kirk GA. Gadodiamide-associated nephrogenic systemic fibrosis. why radiologists should be concerned. AJR Am J Roentgenol. 2007;188:586-592.
-
(2007)
AJR Am J Roentgenol
, vol.188
, pp. 586-592
-
-
Broome, D.R.1
Girguis, M.S.2
Baron, P.W.3
Cottrell, A.C.4
Kjellin, I.5
Kirk, G.A.6
-
15
-
-
34648821231
-
Transglutaminases: The missing link in nephrogenic systemic fibrosis
-
Parsons AC, Yosipovitch G, Sheehan DJ, Sangueza OP, Greenberg CS, Sane DC. Transglutaminases: the missing link in nephrogenic systemic fibrosis. Am J Dermatopathol. 2007;29:433-436.
-
(2007)
Am J Dermatopathol
, vol.29
, pp. 433-436
-
-
Parsons, A.C.1
Yosipovitch, G.2
Sheehan, D.J.3
Sangueza, O.P.4
Greenberg, C.S.5
Sane, D.C.6
-
16
-
-
33845879909
-
Gadolinium is detectable within the tissue of patients with nephrogenic systemic fibrosis
-
Jan;
-
High WA, Ayers RA, Chandler J, Zito G, Cowper SE. Gadolinium is detectable within the tissue of patients with nephrogenic systemic fibrosis. Am Acad Dermatol. 2007 Jan;56(1):21-6.
-
(2007)
Am Acad Dermatol
, vol.56
, Issue.1
, pp. 21-26
-
-
High, W.A.1
Ayers, R.A.2
Chandler, J.3
Zito, G.4
Cowper, S.E.5
-
17
-
-
33847248060
-
Nephrogenic fibrosis dermopathy associated with exposure to gadolinium-containing contrast agents: St Louis, Missouri, 2002-2006
-
Centers for Disease Control and Prevention CDC
-
Centers for Disease Control and Prevention (CDC). Nephrogenic fibrosis dermopathy associated with exposure to gadolinium-containing contrast agents: St Louis, Missouri, 2002-2006. MMWR Morb Mortal Wkly Rep. 2007;56:137-141.
-
(2007)
MMWR Morb Mortal Wkly Rep
, vol.56
, pp. 137-141
-
-
-
18
-
-
33748049106
-
Nephrogenic systemic fibrosis: Suspected causative role of gadodiamide used for contrast-enhanced magnetic resonance imaging
-
Marckmann P, Skov L, Rossen K. Nephrogenic systemic fibrosis: suspected causative role of gadodiamide used for contrast-enhanced magnetic resonance imaging. J Am Soc Nephrol. 2006;17:2359-2362.
-
(2006)
J Am Soc Nephrol
, vol.17
, pp. 2359-2362
-
-
Marckmann, P.1
Skov, L.2
Rossen, K.3
-
19
-
-
34548358966
-
Gadolinium is not the only trigger for nephrogenic systemic fibrosis: Insights from two cases and review of the recent literature
-
Wahba IM, Simpson EL, White K. Gadolinium is not the only trigger for nephrogenic systemic fibrosis: insights from two cases and review of the recent literature. Am J Transplant. 2007;7:2425-2432.
-
(2007)
Am J Transplant
, vol.7
, pp. 2425-2432
-
-
Wahba, I.M.1
Simpson, E.L.2
White, K.3
-
20
-
-
34147193807
-
Nephrogenic systemic fibrosis: Risk factors and incidence estimation
-
Sadowski EA, Bennet LK, Chan MR. Nephrogenic systemic fibrosis: risk factors and incidence estimation. Radiology. 2007;243:148-157.
-
(2007)
Radiology
, vol.243
, pp. 148-157
-
-
Sadowski, E.A.1
Bennet, L.K.2
Chan, M.R.3
-
21
-
-
33846525037
-
A case of nephrogenic fibrosing dermopathy/nephrogenic systemic fibrosis
-
Weiss AS, Lucia MS, Teitelbaum I. A case of nephrogenic fibrosing dermopathy/nephrogenic systemic fibrosis. Nat Clin Pract Nephrol. 2007;3:111-115.
-
(2007)
Nat Clin Pract Nephrol
, vol.3
, pp. 111-115
-
-
Weiss, A.S.1
Lucia, M.S.2
Teitelbaum, I.3
-
22
-
-
31844452583
-
Description of 12 cases of nephrogenic fibrosing dermopathy and review of the literature
-
Mendoza FA, Artlett CM, Sandorfi N, Latinis K, Piera-Velazquez S, Jmenez SA. Description of 12 cases of nephrogenic fibrosing dermopathy and review of the literature. Semin Arthritis Rheum. 2006;35:238-249.
-
(2006)
Semin Arthritis Rheum
, vol.35
, pp. 238-249
-
-
Mendoza, F.A.1
Artlett, C.M.2
Sandorfi, N.3
Latinis, K.4
Piera-Velazquez, S.5
Jmenez, S.A.6
-
23
-
-
0742287030
-
Nephrogenic fibrosing dermopathy: The first 6 years
-
Cowper SE. Nephrogenic fibrosing dermopathy: the first 6 years. Curr Opin Rheumatol. 2003;15:785-790.
-
(2003)
Curr Opin Rheumatol
, vol.15
, pp. 785-790
-
-
Cowper, S.E.1
-
24
-
-
34250667094
-
Hyperphosphatemia in dialysis patients: The therapeutic role of lanthanum carbonate
-
Cozzolino M, Brancaccio D. Hyperphosphatemia in dialysis patients: the therapeutic role of lanthanum carbonate. Int J Artif Organs. 2007;30:293-300.
-
(2007)
Int J Artif Organs
, vol.30
, pp. 293-300
-
-
Cozzolino, M.1
Brancaccio, D.2
-
25
-
-
32844457995
-
Progressive accumulation of lanthanum in the liver of normal and uremic rats
-
Slatopolsky E, Liapis H, Finch J. Progressive accumulation of lanthanum in the liver of normal and uremic rats. Kidney Int. 2006;68:2809-2813.
-
(2006)
Kidney Int
, vol.68
, pp. 2809-2813
-
-
Slatopolsky, E.1
Liapis, H.2
Finch, J.3
-
26
-
-
35349028390
-
Advisory about gadolinium calls for caution in the treatment of uremic patients with lanthanum carbonate
-
Aime S, Canavese C, Stratta P. Advisory about gadolinium calls for caution in the treatment of uremic patients with lanthanum carbonate. Kidney Int. 2007;72:1162-1163.
-
(2007)
Kidney Int
, vol.72
, pp. 1162-1163
-
-
Aime, S.1
Canavese, C.2
Stratta, P.3
-
27
-
-
40949088206
-
Gadolinium and nephrogenic systemic fibrosis: The evidence of things not seen
-
Kay J. Gadolinium and nephrogenic systemic fibrosis: the evidence of things not seen. Cleve Clin J Med. 2008;75:112-117.
-
(2008)
Cleve Clin J Med
, vol.75
, pp. 112-117
-
-
Kay, J.1
-
28
-
-
34347340885
-
-
Perazella MA. Nephrogenic systemic fibrosis, kidney disease, and gadolinium: is there a link? Clin J Am Soc Nephrol. 2007;2:200-202.
-
Perazella MA. Nephrogenic systemic fibrosis, kidney disease, and gadolinium: is there a link? Clin J Am Soc Nephrol. 2007;2:200-202.
-
-
-
-
30
-
-
33846673048
-
The case for ultraviolet light therapy in nephrogenic fibrosing dermopathy: Report of two cases and review of the literature
-
Wahba IM, White K, Mayer M, Simpson EL. The case for ultraviolet light therapy in nephrogenic fibrosing dermopathy: report of two cases and review of the literature. Nephrol Dial Transplant. 2007;22:631-636.
-
(2007)
Nephrol Dial Transplant
, vol.22
, pp. 631-636
-
-
Wahba, I.M.1
White, K.2
Mayer, M.3
Simpson, E.L.4
-
31
-
-
40449106988
-
Clinical manifestations of gadodiamide-related nephrogenic systemic fibrosis
-
Marckmann P, Skov L, Rossen K, Thomsen HS. Clinical manifestations of gadodiamide-related nephrogenic systemic fibrosis. Clin Nephrol. 2008;69:161-168.
-
(2008)
Clin Nephrol
, vol.69
, pp. 161-168
-
-
Marckmann, P.1
Skov, L.2
Rossen, K.3
Thomsen, H.S.4
|